Eric Rovner, MD
Eric S. Rovner, M.D. is a Professor in the Department of Urology at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He is the director of the Section of Voiding Dysfunction, Female Urology and Urodynamics in the Department of Urology at MUSC. He has a highly specialized clinical practice within Urology and sees mostly patients with complex voiding problems including urinary incontinence, vaginal prolapse, urinary fistulae and neurogenic bladder dysfunction. He is a Board Certified member of the American Urological Association, Fellow of the American College of Surgeons, as well as a member of the Society of Pelvic Surgeons, Society of University Urologists, Societe Internationale D’Urologie, and the Society for Urodynamics and Female Urology among others. Dr. Rovner has served on several committees including the WHO International Consultation on Incontinence and has served on the AUA Urodynamics Guidelines Committee as well as the AUA SUI Guidelines Committee. Dr. Rovner’s research interests include the study of voiding dysfunction, overactive bladder, interstitial cystitis, neurourology and urodynamics. He has held several visiting professorships and is the author of numerous peer-reviewed scientific articles, monographs and book chapters on these topics as well as a books on urodynamics and on urinary incontinence. He has been an invited speaker on numerous occasions throughout the United States and the world, and has been the Principal or co-investigator on multiple grants.
Financial relationships
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Female Pelvic Medicine & Reconstructive Surgery)Ineligible company:uromedicaDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)Ineligible company:ValenciaDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)Ineligible company:astellasDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:HologixDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:BluewindDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Specialty Not Specified)Ineligible company:UrovantDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:AllerganDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:NextMedDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:MedtronicsDate added:Date updated:11/01/2023
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Specialty Not Specified)Ineligible company:NIH/NIDDKDate added:Date updated:11/01/2023